316 related articles for article (PubMed ID: 27114313)
1. Puerarin prevents bone loss in ovariectomized mice and inhibits osteoclast formation in vitro.
Yuan SY; Sheng T; Liu LQ; Zhang YL; Liu XM; Ma T; Zheng H; Yan Y; Ishimi Y; Wang XX
Chin J Nat Med; 2016 Apr; 14(4):265-269. PubMed ID: 27114313
[TBL] [Abstract][Full Text] [Related]
2. Metformin stimulates osteoprotegerin and reduces RANKL expression in osteoblasts and ovariectomized rats.
Mai QG; Zhang ZM; Xu S; Lu M; Zhou RP; Zhao L; Jia CH; Wen ZH; Jin DD; Bai XC
J Cell Biochem; 2011 Oct; 112(10):2902-9. PubMed ID: 21618594
[TBL] [Abstract][Full Text] [Related]
3. Effect of Zuoguiwan on osteoporosis in ovariectomized rats through RANKL/OPG pathway mediated by β2AR.
Liu F; Tan F; Tong W; Fan Q; Ye S; Lu S; Teng Z; Han M; Zhang M; Chai Y
Biomed Pharmacother; 2018 Jul; 103():1052-1060. PubMed ID: 29710663
[TBL] [Abstract][Full Text] [Related]
4. Puerariae radix prevents bone loss in ovariectomized mice.
Wang X; Wu J; Chiba H; Umegaki K; Yamada K; Ishimi Y
J Bone Miner Metab; 2003; 21(5):268-75. PubMed ID: 12928827
[TBL] [Abstract][Full Text] [Related]
5. Production of IL-7 is increased in ovariectomized mice, but not RANKL mRNA expression by osteoblasts/stromal cells in bone, and IL-7 enhances generation of osteoclast precursors in vitro.
Sato T; Watanabe K; Masuhara M; Hada N; Hakeda Y
J Bone Miner Metab; 2007; 25(1):19-27. PubMed ID: 17187190
[TBL] [Abstract][Full Text] [Related]
6. [Effect of Erigeron Breviscapus on the expression of OPG/RANKL/RANK in osteoblasts and pre-osteoclasts in vitro].
Liu CG; Luo QX; Ling TY; Mo YY; Cheng ZL; Huang SG; Mo H
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Dec; 33(12):1658-64. PubMed ID: 24517065
[TBL] [Abstract][Full Text] [Related]
7. Genistein and Silicon Synergistically Protects Against Ovariectomy-Induced Bone Loss Through Upregulating OPG/RANKL Ratio.
Chen C; Zheng H; Qi S
Biol Trace Elem Res; 2019 Apr; 188(2):441-450. PubMed ID: 30014283
[TBL] [Abstract][Full Text] [Related]
8. Puerarin concurrently stimulates osteoprotegerin and inhibits receptor activator of NF-κB ligand (RANKL) and interleukin-6 production in human osteoblastic MG-63 cells.
Wang Y; Yang C; Xie WL; Zhao YW; Li ZM; Sun WJ; Li LZ
Phytomedicine; 2014; 21(8-9):1032-6. PubMed ID: 24854571
[TBL] [Abstract][Full Text] [Related]
9. The cross-talk between osteoclasts and osteoblasts in response to strontium treatment: involvement of osteoprotegerin.
Peng S; Liu XS; Huang S; Li Z; Pan H; Zhen W; Luk KD; Guo XE; Lu WW
Bone; 2011 Dec; 49(6):1290-8. PubMed ID: 21925296
[TBL] [Abstract][Full Text] [Related]
10. Cyperus Rotundus L. extract suppresses RANKL-induced osteoclastogenesis through NFATc1/c-fos downregulation and prevent bone loss in OVX-induced osteoporosis rat.
Kum CJ; Kim EY; Kim JH; Lee B; Min JH; Heo J; Kim JH; Yeom M; Sohn Y; Jung HS
J Ethnopharmacol; 2017 Jun; 205():186-194. PubMed ID: 28315458
[TBL] [Abstract][Full Text] [Related]
11. Effect of esculetin on bone metabolism in ovariectomized rats.
Liu M; Li YBAJDL; Pan J; Liu H; Wang S; Ju D; Wang R; Bai D; Wu J; Sun G; Miao Q; Liu L
J Tradit Chin Med; 2018 Dec; 38(6):896-903. PubMed ID: 32186137
[TBL] [Abstract][Full Text] [Related]
12. Calycosin attenuates osteoporosis and regulates the expression of OPG/RANKL in ovariectomized rats
Li N; Tu Y; Shen Y; Qin Y; Lei C; Liu X
Pharmazie; 2016 Oct; 71(10):607-612. PubMed ID: 29441931
[TBL] [Abstract][Full Text] [Related]
13. Anti-osteoporotic activity of puerarin 6"-O-xyloside on ovariectomized mice and its potential mechanism.
Li H; Chen B; Pang G; Chen J; Xie J; Huang H
Pharm Biol; 2016; 54(1):111-7. PubMed ID: 25857587
[TBL] [Abstract][Full Text] [Related]
14. Bu‑Shen‑Ning‑Xin decoction suppresses osteoclastogenesis by modulating RANKL/OPG imbalance in the CD4+ T lymphocytes of ovariectomized mice.
Zhang JL; Qiu XM; Zhang N; Tang W; Gober HJ; Li DJ; Wang L
Int J Mol Med; 2018 Jul; 42(1):299-308. PubMed ID: 29717766
[TBL] [Abstract][Full Text] [Related]
15. Semen Astragali Complanati- and Rhizoma Cibotii-enhanced bone formation in osteoporosis rats.
Liu M; Xiao GG; Rong P; Dong J; Zhang Z; Zhao H; Teng J; Zhao H; Pan J; Li Y; Zha Q; Zhang Y; Ju D
BMC Complement Altern Med; 2013 Jun; 13():141. PubMed ID: 23782721
[TBL] [Abstract][Full Text] [Related]
16. Effects of JSOG-6 on protection against bone loss in ovariectomized mice through regulation of osteoblast differentiation and osteoclast formation.
Chung HJ; Cho L; Shin JS; Lee J; Ha IH; Park HJ; Lee SK
BMC Complement Altern Med; 2014 Jun; 14():184. PubMed ID: 24903150
[TBL] [Abstract][Full Text] [Related]
17. Icariin protects against bone loss induced by oestrogen deficiency and activates oestrogen receptor-dependent osteoblastic functions in UMR 106 cells.
Mok SK; Chen WF; Lai WP; Leung PC; Wang XL; Yao XS; Wong MS
Br J Pharmacol; 2010 Feb; 159(4):939-49. PubMed ID: 20128811
[TBL] [Abstract][Full Text] [Related]
18. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the effects of genistein and zoledronic acid on the bone loss in OPG-deficient mice.
Liu J; Xu K; Wen G; Guo H; Li S; Wu X; Dai R; Sheng Z; Liao E
Bone; 2008 May; 42(5):950-9. PubMed ID: 18337202
[TBL] [Abstract][Full Text] [Related]
20. ED-71 Improves Bone Mass in Ovariectomized Rats by Inhibiting Osteoclastogenesis Through EphrinB2-EphB4-RANKL/OPG Axis.
Wang K; Kou Y; Rong X; Wei L; Li J; Liu H; Li M; Song H
Drug Des Devel Ther; 2024; 18():1515-1528. PubMed ID: 38716369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]